Featured Opinions
The relationships between pharma companies and healthcare payers are not easy - at best distant and frequently adversarial. However, change seems to be coming.
Ms the Word: Reconnecting with the human touch
*Why everyone benefits from getting the work-life balance right*
Personalized medicine: Regulating companion diagnostics
by Clare Sansom
*Clare Sansom reports on why this is a key time for regulating diagnostics*
Lost Opportunity for Opportunity Management
A 2004 study by Dickie & Trailer reported 'dismal' pipeline analysis in many companies. Why oh why then do so many organisations still get wrapped up in activity analysis?
Ms the Word: Too many meetings
*Why meetings need to be about decision-making, not information sharing.*
E-patients: Educated, engaged, and empowered
by EileenOBrien
*Is pharma ready for the age of the e-patient?* The age of the e-patient has officially arrived.
Ms the Word: A Mercedes in the snow
*What I learned about presenting (and strategy) by not being able to deliver my presentation* Winter has definitely come.
Adherence Arena: Why isnt non-adherence big news?
*A catchier name than medication non-compliance would help* If you believe the numbers, medication non-adherence is a bigger problem for the US than obesity.
Ms the Word: In praise of multitasking
*Not every BlackBerry user is checking the football scores during your presentation*
In better group practice affiliations data just a red herring?
A recent industry survey by ZS Associates about Call Planning Practices in the US shows that almost a third of the companies currently consider group practice affiliations in their call planning, and an additional 40% are planning to do this in the future. So group practices are becoming an important factor.
Sales Manager Hold the Key to Unlocking Sales Performance
by Steven Rosen
The past year was very challenging for many sales managers, but now we need to look ahead.
The patients view: How patients can add value toand influencepharma
by Chris Ogden
*Patients want to be more than market research fodder; we want to be part of the drug discovery process*
Adherence Arena: Compliance or persistenceWhich is more important?
**Why persistence matters in evaluating adherence programs**
A New Year in the Pharmaceutical Industry Solving the Pharmaceutical Industry Woes
by Steven Rosen
Looking toward the upcoming year, many of you have made decisions to reduce the number of sales reps and employees in your respective organizations.
Sales Management Case Studies Five Ways for Sales Leaders to Stay Inspired
by Steven Rosen
Paul Smith is the Sales Director of a leading pharmaceutical company. He has been in the industry for the last 10 years and has been a star in his various sales and marketing roles.
Mal's Musings: Evidence-based medicineThe end of pharma marketers?
*For marketing success, build proof of value not clever campaigns*
Personalised Medicine: great for patients, bad for business?
by Anonymous (not verified)
The concept of personalised medicine has always been at the heart of every physician's decision making process but the "one-treatment-fits-all-disease-phenotypes" is very often not satisfactory.